In the next sections, we will focus on the role of P2X7 receptor in the development and possible treatment of the neurodegenerative disorders that most heavily affect patients worldwide: Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and Multiple Sclerosis (MS). Here, P2RX7 is linked to early-onset autosomal dominant Alzheimer disease.